E L Nassonov

456 total citations
22 papers, 315 citations indexed

About

E L Nassonov is a scholar working on Rheumatology, Immunology and Epidemiology. According to data from OpenAlex, E L Nassonov has authored 22 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Rheumatology, 5 papers in Immunology and 4 papers in Epidemiology. Recurrent topics in E L Nassonov's work include Rheumatoid Arthritis Research and Therapies (5 papers), Systemic Lupus Erythematosus Research (3 papers) and Systemic Sclerosis and Related Diseases (3 papers). E L Nassonov is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (5 papers), Systemic Lupus Erythematosus Research (3 papers) and Systemic Sclerosis and Related Diseases (3 papers). E L Nassonov collaborates with scholars based in Russia, Austria and France. E L Nassonov's co-authors include Pierre Youinou, Maryvonne Dueymes, Samsonov MIu, Konstantin V. Salojin, H. Wächter, Jean‐Charles Piette, Alain Saraux, Gilbert Reibnegger, Gernot P. Tilz and Dietmar Fuchs and has published in prestigious journals such as The American Journal of Medicine, European Heart Journal and Clinical Chemistry.

In The Last Decade

E L Nassonov

21 papers receiving 302 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E L Nassonov Russia 10 105 100 93 82 51 22 315
Michela Pinnelli Italy 8 111 1.1× 49 0.5× 216 2.3× 62 0.8× 50 1.0× 8 437
H Gur Israel 9 37 0.4× 119 1.2× 74 0.8× 47 0.6× 102 2.0× 20 353
Magdalena Dryglewska Poland 12 107 1.0× 144 1.4× 68 0.7× 63 0.8× 36 0.7× 36 359
Mario Jiménez-Hernández Spain 12 60 0.6× 235 2.4× 120 1.3× 89 1.1× 66 1.3× 27 606
Bożena Dziankowska‐Bartkowiak Poland 12 211 2.0× 42 0.4× 86 0.9× 91 1.1× 57 1.1× 39 351
Michiaki Tokuda Japan 13 90 0.9× 112 1.1× 77 0.8× 37 0.5× 131 2.6× 21 381
F. Luccioli Italy 11 65 0.6× 174 1.7× 94 1.0× 86 1.0× 25 0.5× 19 441
E. Prati Italy 11 52 0.5× 156 1.6× 109 1.2× 137 1.7× 22 0.4× 21 516
Paul Bălănescu Romania 14 94 0.9× 141 1.4× 196 2.1× 74 0.9× 70 1.4× 54 524
Edit Végh Hungary 12 47 0.4× 257 2.6× 143 1.5× 66 0.8× 44 0.9× 28 440

Countries citing papers authored by E L Nassonov

Since Specialization
Citations

This map shows the geographic impact of E L Nassonov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E L Nassonov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E L Nassonov more than expected).

Fields of papers citing papers by E L Nassonov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E L Nassonov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E L Nassonov. The network helps show where E L Nassonov may publish in the future.

Co-authorship network of co-authors of E L Nassonov

This figure shows the co-authorship network connecting the top 25 collaborators of E L Nassonov. A scholar is included among the top collaborators of E L Nassonov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E L Nassonov. E L Nassonov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Каратеев, Д. Е., E L Nassonov, Е. Л. Лучихина, et al.. (2016). AB0299 The Reasons for Withdrawal of Biological Dmards According To The Russian Registry of Patients with Rheumatoid Arthritis. Annals of the Rheumatic Diseases. 75. 1002–1002. 1 indexed citations
2.
Nassonov, E L, et al.. (2005). Rheumatic diseases and rheumatological service in the Central Federal District of Russia. Rheumatology Science and Practice. 0(4). 4–4. 1 indexed citations
3.
Nassonov, E L, et al.. (2005). New approaches to the assessment of rheumatoid arthritis activity: Simplified Disease Activity Index (SDAI) TOC \o "1-5" \h \z in early arthritis. Rheumatology Science and Practice. 0(2). 7–7. 1 indexed citations
4.
Коротаева, Т. В., et al.. (2004). Administration of phospholipide hepatoprotective drug Phosphogliv in patients with psoriatic arthritis (preliminary results). Rheumatology Science and Practice. 0(3). 40–40. 1 indexed citations
5.
Alekberova, Z S, et al.. (2004). Cardiovascular disturbances and atherosclerosis risk Гасtore in systemic lupus erythematosus. Rheumatology Science and Practice. 0(4). 10–10. 4 indexed citations
7.
Калашникова, Л А, Z S Alekberova, V A Nassonova, et al.. (2004). Clinical and immunological features of primary and secondary antiphospholipid syndrome. Rheumatology Science and Practice. 0(4). 15–15. 1 indexed citations
8.
Каратеев, А. Е. & E L Nassonov. (2003). Non-ulcer dyspepsia associated with NSAID intake: possibility of antacid drugs application. Rheumatology Science and Practice. 0(2). 28–28. 2 indexed citations
9.
Nassonov, E L, et al.. (2003). Gastroduodenal safety of Nimesulid (Nimesil, Berlin Chemie) in rheumatic patients with history of ulcer. Rheumatology Science and Practice. 0(1). 36–36. 4 indexed citations
10.
Salojin, Konstantin V., Alain Saraux, E L Nassonov, et al.. (1997). Antiendothelial Cell Antibodies: Useful Markers of Systemic Sclerosis. The American Journal of Medicine. 102(2). 178–185. 88 indexed citations
11.
MIu, Samsonov, E L Nassonov, Gernot P. Tilz, et al.. (1997). Elevated serum levels of neopterin in adult patients with polymyositis/dermatomyositis. Lara D. Veeken. 36(6). 656–660. 20 indexed citations
12.
Bokarewa, Maria, А. А. Баранов, E L Nassonov, & L. Robert. (1996). Elastin degradation in systemic vasculitis.. PubMed. 44(4). 254–8. 5 indexed citations
13.
MIu, Samsonov, Gernot P. Tilz, Gilbert Reibnegger, et al.. (1995). Serum-Soluble Receptors for Tumor Necrosis Factor-α and Interleukin-2, and Neopterin in Acute Rheumatic Fever. Clinical Immunology and Immunopathology. 74(1). 31–34. 24 indexed citations
14.
Nassonov, E L, et al.. (1995). Serum neopterin concentrations in Wegener's granulomatosis correlate with vasculitis activity.. PubMed. 13(3). 353–6. 12 indexed citations
15.
Dueymes, Maryvonne, et al.. (1995). Role of β2-glycoprotein I in the antiphospholipid antibody binding to endothelial cells. Lupus. 4(3). 179–186. 41 indexed citations
16.
MIu, Samsonov, Gilbert Reibnegger, E L Nassonov, et al.. (1993). Elevated Serum Neopterin Levels in Acute Rheumatic Fever. Pteridines. 4(1). 39–42. 2 indexed citations
17.
Fuchs, D., Samsonov MIu, Gernot P. Tilz, et al.. (1993). Stimulated Cellular Immune System in Patients with Congestive Heart Failure. Clinical Chemistry and Laboratory Medicine (CCLM). 31(3). 111–4. 17 indexed citations
18.
MIu, Samsonov, et al.. (1993). Anaphylatoxins in dilated cardiomyopathy. Journal of Internal Medicine. 234(2). 139–142. 5 indexed citations
19.
MIu, Samsonov, et al.. (1992). Patterns of Serological Markers for Cellular Immune Activation in Patients with Dilated Cardiomyopathy and Chronic Myocarditis. Clinical Chemistry. 38(5). 678–680. 25 indexed citations
20.
MIu, Samsonov, et al.. (1991). Serum neopterin--possible immunological marker of myocardial inflammation in patients with dilated heart muscle disease. European Heart Journal. 12(suppl D). 151–153. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026